Synthetic Biology and the Frontiers of Technology

Total Page:16

File Type:pdf, Size:1020Kb

Synthetic Biology and the Frontiers of Technology ynthetic biology, or the application of engineering acids in ways never seen in nature. Advances in molecular engineer- principles to the design of life, presents world-changing ing are driving the construction of ever-more complex circuits made prospects. Could components of a living cell function from biological materials. And the ability to freeze-dry cellular tran- as tiny switches or circuits? How would that allow bio- scription machinery outside the confines of cells has enabled scien- medical engineers to build biological “smart devices”— tists to easily manufacture proteins at will, at any time and place. Sfrom sensors deployed inside the body to portable medical kits able Most synthetic biology today centers on single-celled organ- to produce vaccines and antibiotics on demand? Could bacterial isms, such as the bacterium Escherichia coli. In the spring of 2019, for “factories” replace the fossil-fueled industries that produce plas- example, researchers at the University of Cambridge announced tics, foods, and fertilizers? Will the secrets of living creatures that that they had synthesized an entire E. coli genome—the bacterium’s enter suspended animation during periods of drought and extreme complete set of genetic material—and swapped it into living E. coli cold be harnessed to keep human victims of trauma alive? And is cells. Their version, which at four million base pairs (the building the genetic information preserved in long-frozen or fossilized ex- blocks of the DNA double helix) was then the largest synthetic ge- tinct species, like woolly mammoths, sufficiently recoverable to nome created to date, was nevertheless a pared-down variant that help save living species? eliminated redundancies, thereby simplifying the biological com- These ideas, once the stuff of science fic- Synthetic biology plexity evolved over millennia and making tion, are now the stuff ofscience. Some aren’t the organism easier for human engineers to yet functioning realities, but others have understand and manipulate. Although the launched business applications, whether in and the frontiers bacteria with synthetic genomes were not medicine (such as hospital gowns that sig- as robust as their natural counterparts, and nal exposure to infection) or in land reme- of technology reproduced slowly, they survived. diation (where bacterial “factories” pow- The scientists who do this work know ered by the sun capture nitrogen from the that they are operating in a new domain, atmosphere to help plants grow). Someday, with transformative possibilities. James engineered forms of life that store carbon by Jonathan Shaw Collins, a core faculty member at the Wyss may even be one of the solutions to Earth’s Institute who 20 years ago created one of the climate-change problem. first biological circuits, believes this synthet- “Most of biology, historically, has been ic, engineered biology “will be a defining, if analyzing how nature works,” says Don- not the defining, technology of the century.” ald Ingber, director of Harvard’s Wyss Institute for Biologically Snapshots of the evolving technologies follow. Inspired Engineering. Systems biology is the culmination of that ef- fort to deconstruct natural processes. Now, with synthetic biology, Switches, Sensors, and Medicines on Demand he points out, scientists “are at the point where we know enough In January 2000, Collins and a team at Princeton, working sep- that we can actually engineer artificial and natural biological sys- arately, simultaneously published in Nature the first designs for tems.” Researchers today can build things from biological parts, and switches made from biological parts. That innovation arguably even create hybrid systems by linking them to non-living machines. marked the beginning of modern synthetic biology. Collins had Propelling the science forward are scores of innovations in bio- engineered a switch, like the push button on a desk lamp: press logical science, with new discoveries coming every month. Among once, the light turns on; press again, it turns off. Collins’s simple the most important are advances in genetic editing, including im- mechanism was not built from metal and plastic, but from two genes provements in accuracy, and the ability to make hundreds of changes that flip-flopped between on and off states when stimulated by at once. Another is computer-aided design, widely used to model chemical signals or changes in temperature. It was a simple circuit. biological systems, and to build new proteins by combining amino The simplicity of what Collins had created belied its potential. Harvard Magazine 37 Reprinted from Harvard Magazine. For more information, contact Harvard Magazine, Inc. at 617-495-5746 The ability to engineer biological circuits in this way meant that signed to combine systematically with an opposite RNA strand cells could represent binary states such as the zeros and ones that associated with a bacterial pathogen. That opens the switch, which are the basis of computer systems. They could perform simple logic. then releases a fluorescent particle that reveals the presence of And because they could be programmed to die after a certain num- the pathogen. ber of cell divisions, they enabled the creation of the first kill-switch To effect this, researchers must engineer biological circuits and safety mechanisms to prevent organisms with synthetic parts from insert them into living bacteria: a process that sounds formidably escaping into the environment. complex. But scientists know that different kinds of bacteria, in Many of the earliest biological switches were crude and prone the course of evolutionary history, have routinely exchanged whole to accidental triggering. The inside of even a single-celled bacte- “cassettes” of many genes, such as those that control metabolism. rium such as E. coli, where engineered synthetic circuits are often This swapping of genetic material is called “horizontal gene trans- James Collins introduced and tested, is very busy. There are “many molecules, fer.” Within these cassettes that control particular biological func- large and small, interacting in a very small space,” explains Col- tions, researchers have devised ways to alter specific genes, and then lins, who teaches in the Harvard-MIT Program in Health Sciences reinject the whole functioning circuit into a cell. and Technology. All this activity can lead to what engineers call These genetic circuits control what proteins the cell produces. “crosstalk,” instances when a stray signal can accidentally flip a Since the 1960s, biologists have known that the protein-synthesiz- simple switch. Such unpredictable behavior would be anathema ing machinery of a bacterium can even be plucked from within the in biomedical applications. cell’s protective outer membrane, placed in a laboratory test tube But biological switches have become much more robust since or petri dish, and still function. 2000, allowing them to be used in laboratory animals as reliable In October 2014, the field took another leap forward when the detectors that signal the presence of pathogens. In applications Collins lab published a serendipitous discovery that advanced the in the gut, for example, RNA-based switches have been designed practicality of using RNA-based switches as detectors in the field— to release appropriate probiotic therapies. Such an RNA-based and even as therapy-producing agents. While working to develop switch takes advantage of the fact that the bases on a single strand encapsulated cell-free genetic networks for cellular reprogramming, of RNA want to pair with opposite bases, just as “A[denine] goes postdoctoral student Keith Pardee discovered that a cell’s tran- to T[hymine] and G[uanine] goes to C[ytosine]” in DNA base pair- scription and translation machinery (the parts that build proteins ing, Collins explains. This means that an RNA probe can be de- from DNA instructions) could be spotted onto a piece of paper, 38 January - February 2020 Portraits by Jim Harrison Reprinted from Harvard Magazine. For more information, contact Harvard Magazine, Inc. at 617-495-5746 The lab’s first deployment of the technology was to create a detector for Ebola, a rare but deadly disease that has killed thousands of people in West Africa. freeze-dried, and then restored to full function when rehydrated. scription and translation—the parts that enable that modified DNA The lab’s first deployment of the technology was to create a detec- with its associated genes to be “turned on and express the relevant tor for Ebola, a rare but deadly disease that has killed thousands of proteins.” In the case of diagnostics, the rehydration that activates people in West Africa. Subsequent testing revealed that their Ebola protein production might be a patient’s blood, urine, or sputum. In detector remained viable for a year or more—without the need for the case of therapeutics, adding water is enough to revive the ma- refrigeration. This was significant, because Ebola often strikes in chinery for making vaccines or antibiotics. This has enabled his lab to remote regions poorly served by healthcare facilities. develop field kits the size of a small cellphone that could be carried The lab has subsequently used the same techniques to make di- “by soldiers or hikers or astronauts, athletes, or healthcare workers agnostics for the Zika virus, for gut microbiome analysis, and for detecting antibiotic resistance. “We now have ef- forts underway looking at Lyme dis- ease, HIV, TB, HPV, and hepatitis C,” says Collins.
Recommended publications
  • Physiology of Highly Radioresistant Escherichia Coli After Experimental Evolution for 100 Cycles of Selection
    Lawrence Berkeley National Laboratory Recent Work Title Physiology of Highly Radioresistant Escherichia coli After Experimental Evolution for 100 Cycles of Selection. Permalink https://escholarship.org/uc/item/5bj102bg Authors Bruckbauer, Steven T Martin, Joel Minkoff, Benjamin B et al. Publication Date 2020 DOI 10.3389/fmicb.2020.582590 Peer reviewed eScholarship.org Powered by the California Digital Library University of California fmicb-11-582590 September 17, 2020 Time: 16:43 # 1 ORIGINAL RESEARCH published: 22 September 2020 doi: 10.3389/fmicb.2020.582590 Physiology of Highly Radioresistant Escherichia coli After Experimental Evolution for 100 Cycles of Selection Steven T. Bruckbauer1, Joel Martin2, Benjamin B. Minkoff1,3, Mike T. Veling4, Illissa Lancaster1, Jessica Liu1, Joseph D. Trimarco1†, Brian Bushnell2, Anna Lipzen2, Elizabeth A. Wood1, Michael R. Sussman1,3, Christa Pennacchio2 and Michael M. Cox1* Edited by: Vasco Ariston De Carvalho 1 Department of Biochemistry, University of Wisconsin-Madison, Madison, WI, United States, 2 DOE Joint Genome Institute, Azevedo, Berkeley, CA, United States, 3 Center for Genomic Science Innovation, University of Wisconsin School of Medicine and Public Federal University of Minas Gerais, Health, Madison, WI, United States, 4 Department of Systems Biology, Harvard Medical School, Boston, MA, United States Brazil Reviewed by: Bing Tian, Ionizing radiation (IR) is lethal to most organisms at high doses, damaging every cellular Zhejiang University, China macromolecule via induction of reactive oxygen species (ROS). Utilizing experimental Vera Y. Matrosova, evolution and continuing previous work, we have generated the most IR-resistant Henry M. Jackson Foundation for the Advancement of Military Escherichia coli populations developed to date. After 100 cycles of selection, the Medicine, United States dose required to kill 99% the four replicate populations (IR9-100, IR10-100, IR11- Suzanne Sommer, Université Paris-Saclay, France 100, and IR12-100) has increased from 750 Gy to approximately 3,000 Gy.
    [Show full text]
  • Biology, Adaptability, and the Economic Applications of Tardigrades in Future
    Journal of Science and Technology ISSN: 2456-5660 Volume 06, Issue 01, Jan-February 2021 www.jst.org.in DOI: https://doi.org/10.46243/jst.2021.v6.i1.pp109-117 Biology, Adaptability, and The Economic Applications of Tardigrades In Future Ms. Afreen s. Shaikh1, Dr. Anis B. Chaoudhery2 1(Department of Oceanography, Sindhu Swadhay Sanstha, Kalyan, University of Mumbai. District Thane, Maharashtra, India) 2(Department of zoology, G.M.MominWomens college, Bhiwandi, University of Mumbai, District Thane, Maharashtra, India) 2Corresponding Author: [email protected] To Cite this Article Ms. Afreen s. Shaikh, Dr. Anis B. Chaoudhery, “Biology, Adaptability, and The Economic Applications of Tardigrades In Future”, Journal of Science and Technology, Vol. 06, Issue 01, Jan-February 2021, pp109-117 Article Info Received: 28-08-2020 Revised: 18-11-2020 Accepted: 26-11-2020 Published: 27-12-2020 Abstract: Tardigrades are small microscopic creatures also known as moss piglets or water bears. They are extremophiles and well known for its survivability. After successfully ruling the space tardigrades are now expected to save lives. From being a ‘survivor’ tardigrade is now headed to be a ‘savior’. This survivability is due to a special type of sugar known as “Trehalose”. Trehalose can be found in extremophiles organisms including tardigrades. The unique feature of this sugar is the ability to preserve biological molecules. One of the big applications of the tardigrades are the “dry vaccine”. Our world is struggling through a big crisis of covid-19 vaccine, it is next to impossible to make the highest demanded vaccine available to every corner of the earth at the low-temperature range in such a short period of time, and according to WHO half of the vaccines get wasted due to the cold chain method So, we can implement these dry vaccines for covid-19, to reduce the freezing cost, increasing the shelf life of vaccine and make every vaccine reach to needy in a live condition.
    [Show full text]
  • Cryonics Magazine, Q3 1998
    Letters to the Editor To the Editor: him. Oddly, both authors share one article and byline: Thomas Donaldson. s the Hitchhiker’s Guide Your readers may have noticed certain to the Galaxy suggests, sharp disagreements in Cryonics (2nd Qtr. —K. Eric Drexler A 1998). “Don’t Panic.” Despite the In that issue, Author 1 calls for further Thomas Donaldson replies: title of this issue’s feature story, study of how freezing damage could be “The Failure of Cryonics,” I repaired by nanomedical technologies. He It seems to me that my statements are don’t believe that cryonics has notes that this effort “...need not actually quoted out of context, and in many cases solve [the problem of inferring neural con- context is important. failed and I don’t believe that nectivity] in practice,” which would be be- First of all, there is an issue of what it will fail. yond current technological abilities, and “nanotechnology” is to include. If Why am I printing this ar- asks instead for scenarios that start with nanotechnology means the manipulation of ticle then? Because I do be- “the damage that really occurs, then specify matter on a molecular scale, chemists have lieve that the cryonics com- the biochemicals or other concrete items” now done that for over a century, and their enabling the required inference. abilities to do so have increased a great munity holds valid opinions Author 2, in contrast, argues that “only deal. Biochemists have come on the scene besides my own. As I prom- solving the problem theoretically would be and proceeded to manipulate those chemi- ised from my first issue, Cry- cheating,” and asks not for specifications, cals which play a major role in our own onics is aimed at all cryonicists, but for “experiments” in this area.
    [Show full text]
  • Physiology of Highly Radioresistant Escherichia Coli After Experimental Evolution for 100 Cycles of Selection
    fmicb-11-582590 September 17, 2020 Time: 16:43 # 1 ORIGINAL RESEARCH published: 22 September 2020 doi: 10.3389/fmicb.2020.582590 Physiology of Highly Radioresistant Escherichia coli After Experimental Evolution for 100 Cycles of Selection Steven T. Bruckbauer1, Joel Martin2, Benjamin B. Minkoff1,3, Mike T. Veling4, Illissa Lancaster1, Jessica Liu1, Joseph D. Trimarco1†, Brian Bushnell2, Anna Lipzen2, Elizabeth A. Wood1, Michael R. Sussman1,3, Christa Pennacchio2 and Michael M. Cox1* Edited by: Vasco Ariston De Carvalho 1 Department of Biochemistry, University of Wisconsin-Madison, Madison, WI, United States, 2 DOE Joint Genome Institute, Azevedo, Berkeley, CA, United States, 3 Center for Genomic Science Innovation, University of Wisconsin School of Medicine and Public Federal University of Minas Gerais, Health, Madison, WI, United States, 4 Department of Systems Biology, Harvard Medical School, Boston, MA, United States Brazil Reviewed by: Bing Tian, Ionizing radiation (IR) is lethal to most organisms at high doses, damaging every cellular Zhejiang University, China macromolecule via induction of reactive oxygen species (ROS). Utilizing experimental Vera Y. Matrosova, evolution and continuing previous work, we have generated the most IR-resistant Henry M. Jackson Foundation for the Advancement of Military Escherichia coli populations developed to date. After 100 cycles of selection, the Medicine, United States dose required to kill 99% the four replicate populations (IR9-100, IR10-100, IR11- Suzanne Sommer, Université Paris-Saclay, France 100, and IR12-100) has increased from 750 Gy to approximately 3,000 Gy. Fitness *Correspondence: trade-offs, specialization, and clonal interference are evident. Long-lived competing sub- Michael M. Cox populations are present in three of the four lineages.
    [Show full text]
  • Program BAA Template
    Broad Agency Announcement Biostasis BIOLOGICAL TECHNOLOGIES OFFICE HR001118S0034 March 16, 2018 HR001118S0034, Biostasis TABLE OF CONTENTS PART I: OVERVIEW INFORMATION ....................................................................................3 PART II: FULL TEXT OF ANNOUNCEMENT.......................................................................4 1. Funding Opportunity Description.....................................................................................4 1.1. Program Overview ......................................................................................................4 1.2. Program Structure and Technical Approach ...........................................................5 1.3. End of Phase Demonstrations ....................................................................................7 1.4. Program Metrics..........................................................................................................8 2. Award Information...........................................................................................................12 2.1. General award information......................................................................................12 2.2. Fundamental Research .............................................................................................13 3. Eligibility Information......................................................................................................13 3.1. Eligible Applicants ....................................................................................................13
    [Show full text]
  • ROGER LARKEN CHANG, Ph.D
    Roger L. Chang, Harvard Medical School Curriculum Vitae | p. 1 of 9 ROGER LARKEN CHANG, Ph.D. 210 Longwood Avenue, Armenise 623 [email protected] Department of Systems Biology Phone: 858-349-5380 Harvard Medical School http://silver.med.harvard.edu/index.php/people/#RLC Boston, MA 02115 Place of Birth: Euless, TX EDUCATION 2012 Ph.D. Bioinformatics and Systems Biology, University of California San Diego Co-Advisors: Bernhard Ø. Palsson, Ph.D. and Philip E. Bourne, Ph.D. Thesis: Structural Systems Biology Perspective on the Metabolic Impact of Physicochemical Stress 2005 B.A. Molecular and Cell Biology (genetics & development emphasis), University of California Berkeley RESEARCH EXPERIENCE Research associate and associate lab director, Harvard Medical School 2018-present Primary Projects: • Design of intrinsically disordered proteins (IDPs) to induce cryptobiosis in human cells: developed 5-year $15M proposal, acted as project manager, performed computational analysis and design of IDPs, and enzyme stabilization assays LSRF postdoctoral research fellow, Harvard Medical School 2013-2018 Advisor: Pamela A. Silver, Ph.D. Primary Projects: • Discovery of viral-encoded suppressors of innate immunity in humans: helped develop protein structure- based prediction method to identify immunosuppressors, developed automated gene expression construct design pipeline, advised on development of unsupervised learning analysis of high-throughput microscopy imaging data to establish immune response assay phenotypes, maintained human cell cultures
    [Show full text]